ES2062303T3 - Agentes antipsicoticos espirociclicos. - Google Patents

Agentes antipsicoticos espirociclicos.

Info

Publication number
ES2062303T3
ES2062303T3 ES90202012T ES90202012T ES2062303T3 ES 2062303 T3 ES2062303 T3 ES 2062303T3 ES 90202012 T ES90202012 T ES 90202012T ES 90202012 T ES90202012 T ES 90202012T ES 2062303 T3 ES2062303 T3 ES 2062303T3
Authority
ES
Spain
Prior art keywords
spyrocyclic
antipsychotic agents
spiro
piperidine
dihydronaphthalene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90202012T
Other languages
English (en)
Inventor
David Charles Billington
Mark Stuart Chambers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of ES2062303T3 publication Critical patent/ES2062303T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

UN TIPO DE DERIVADO DE ESPIRO(1,2,3,4-TETRAHIDRONAFTALENA-1,4-PIPERIDINA) Y ESPIRO(1,4-DIHIDRONAFTALENA-1,4-PIPERIDINA) SON LIGANDOS SELECTIVOS DE RECONOCIMIENTO SIGMA, Y POR ELLO UTILES EN EL TRATAMIENTO Y/O PREVENCION DE ENFERMEDADES PSIQUICAS.
ES90202012T 1989-07-26 1990-07-23 Agentes antipsicoticos espirociclicos. Expired - Lifetime ES2062303T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898917069A GB8917069D0 (en) 1989-07-26 1989-07-26 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2062303T3 true ES2062303T3 (es) 1994-12-16

Family

ID=10660644

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90202012T Expired - Lifetime ES2062303T3 (es) 1989-07-26 1990-07-23 Agentes antipsicoticos espirociclicos.

Country Status (17)

Country Link
EP (1) EP0414289B1 (es)
JP (1) JPH03184959A (es)
KR (1) KR910002444A (es)
AT (1) ATE101854T1 (es)
AU (1) AU628612B2 (es)
CA (1) CA2021736A1 (es)
DE (1) DE69006799T2 (es)
DK (1) DK0414289T3 (es)
ES (1) ES2062303T3 (es)
FI (1) FI903728A0 (es)
GB (1) GB8917069D0 (es)
IE (1) IE902706A1 (es)
IL (1) IL95124A0 (es)
NO (1) NO903315L (es)
NZ (1) NZ234557A (es)
PT (1) PT94806A (es)
ZA (1) ZA905841B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0445974A3 (en) * 1990-03-05 1992-04-29 Merck Sharp & Dohme Ltd. Spirocyclic antipsychotic agents
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
CA2143117A1 (en) * 1992-10-07 1994-04-14 Ben E. Evans Tocolytic oxytocin receptor antagonists
US5670509A (en) * 1993-09-27 1997-09-23 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
AU2223495A (en) * 1994-04-15 1995-11-10 Yamanouchi Pharmaceutical Co., Ltd. Spiro compound and medicinal composition thereof
PL357340A1 (en) * 1999-06-07 2004-07-26 Warner-Lambert Company Tricyclic analgesics
US7045527B2 (en) 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
EP1737809B1 (en) 2004-02-27 2013-09-18 Amgen, Inc Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
US7786141B2 (en) 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
WO2006023852A2 (en) * 2004-08-19 2006-03-02 Vertex Pharmaceuticals, Incorporated Modulators of muscarinic receptors
EP2325174A1 (en) 2004-08-27 2011-05-25 Laboratorios Del. Dr. Esteve, S.A. Sigma receptor inhibitors
DK1781618T3 (da) 2004-08-27 2012-10-29 Esteve Labor Dr Sigma-receptorinhibitorer
CA2577089A1 (en) 2004-08-27 2006-03-02 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
EP1634873A1 (en) 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
US7863449B2 (en) 2004-11-29 2011-01-04 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP1924546A1 (en) 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
AU2006330866A1 (en) 2005-12-22 2007-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
JP2009527568A (ja) 2006-02-22 2009-07-30 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体の調節剤
KR20080098070A (ko) 2006-02-22 2008-11-06 버텍스 파마슈티칼스 인코포레이티드 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘
EP1829875A1 (en) 2006-03-01 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors
WO2007098953A1 (en) * 2006-03-01 2007-09-07 Laboratorios Del Dr. Esteve, S.A. Pyrazole derivatives as sigma receptor inhibitors
EP1829866A1 (en) 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
EP1829867A1 (en) 2006-03-03 2007-09-05 Laboratorios Del Dr. Esteve, S.A. Imidazole compounds having pharmaceutical activity towards the sigma receptor
JP2009542670A (ja) 2006-06-29 2009-12-03 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体の調節剤
WO2008021375A2 (en) 2006-08-15 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
JP2010501561A (ja) 2006-08-18 2010-01-21 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体の調節剤
AU2007292816B2 (en) 2006-09-07 2011-11-17 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
EP2064193A1 (en) 2006-09-07 2009-06-03 Amgen, Inc Heterocyclic gpr40 modulators
CA2683751C (en) 2007-04-16 2013-01-08 Amgen Inc. Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
MX2010003373A (es) 2007-10-03 2010-04-30 Vertex Pharma Moduladores de receptores muscarinicos.
BRPI0818253A2 (pt) 2007-10-10 2015-04-07 Amgen Inc Moduladores de gpr40 bifenil substituídos
EP2260017A1 (en) 2008-03-06 2010-12-15 Amgen, Inc Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
JP5551707B2 (ja) 2008-10-15 2014-07-16 アムジエン・インコーポレーテツド スピロ環ｇｐｒ４０調節因子
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2395003A1 (en) 2010-05-27 2011-12-14 Laboratorios Del. Dr. Esteve, S.A. Pyrazole compounds as sigma receptor inhibitors
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
SG11201604480PA (en) 2013-12-17 2016-07-28 Esteve Labor Dr SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides

Also Published As

Publication number Publication date
DK0414289T3 (da) 1994-04-11
JPH03184959A (ja) 1991-08-12
NO903315D0 (no) 1990-07-25
PT94806A (pt) 1991-03-20
AU628612B2 (en) 1992-09-17
NO903315L (no) 1991-01-28
EP0414289A1 (en) 1991-02-27
IE902706A1 (en) 1991-02-27
NZ234557A (en) 1992-12-23
EP0414289B1 (en) 1994-02-23
DE69006799D1 (de) 1994-03-31
CA2021736A1 (en) 1991-01-27
ATE101854T1 (de) 1994-03-15
KR910002444A (ko) 1991-02-25
ZA905841B (en) 1991-06-26
GB8917069D0 (en) 1989-09-13
IL95124A0 (en) 1991-06-10
AU5984490A (en) 1991-01-31
DE69006799T2 (de) 1994-08-11
FI903728A0 (fi) 1990-07-25

Similar Documents

Publication Publication Date Title
ES2062303T3 (es) Agentes antipsicoticos espirociclicos.
DE69203928D1 (de) Fahrzeugmontageverfahren und Fahrzeugkarosserie.
NO900853L (no) Slitebane for kjoeretoeydekk med midtre partier forsynt medskraa innsnitt.
NO990542L (no) K-252a-derivater og anvendelse av K-252a-derivater
DE69022567D1 (de) Polycarbonat-polydimethylsiloxan copolymer und herstellungsverfahren.
DE68912148D1 (de) Fahrzeug-Wechselstromgenerator und Herstellungsverfahren.
DE3779290D1 (de) Maschine zum formen von konus und flansch an spruehdosen und dergleichen.
DE58900363D1 (de) Vorrichtung zum aufrichten und aufreihen von formteilen.
DE69206496D1 (de) Elektroplattierungsverfahren und Zusammenstellung.
ATE86490T1 (de) Tracheobronchodilatator.
EP0410535A3 (en) Octahydrobenzisoquinoline derivatives as antipsychotic agents
ATE69235T1 (de) Erythromycin-a-derivate, modifiziert in position- c-12.
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
TW197422B (es)
DE59003441D1 (de) Schweissverfahren und Vorrichtung.
ES2017452A4 (es) Procesos de lecho fluidificado.
DE68903360D1 (de) Hydropneumatische aufhaengungsvorrichtung und mit dieser vorrichtung ausgestattetes fahrzeug.
DE58903780D1 (de) N-substituierte 3,4,5,6-tetrahydrophthalimid-derivate.
ATE104289T1 (de) Aminoethylthiazole und aminoethyloxazol-derivate.
DE3885756D1 (de) Klemmbuchse und Ausgleichsscheibe.
KR950702558A (ko) 신경이완제 등으로서 유용한 N-치환된 3-아자비시클로[3.2.0]헵탄 유도체(N-Substituted 3-Azabicyclo[3.2.0]Heptane Derivates Useful as Neuroleptic Agents, ets.)
ES1004386Y (es) Maquina dosificadora-llenadora de botellas y similares.
LV5739B4 (lv) 1-Azatriciklo[7.2.03,8]undec-2-en-2-karbonskabes atvasinajumi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 414289

Country of ref document: ES